17α-Hydroxy-Progesterone Effects on Cervical Proinflammatory Agents in Women at Risk for Preterm Delivery

 

 Buy Article Permissions and Reprints

ABSTRACT

We evaluated if the inhibitory effect of 17α-hydroxyprogesterone caproate (17P) on cervical ripening is mediated by cervical proinflammatory agents. Women with singleton pregnancy and intact membranes, between 25 and 33 weeks + 6 days, were randomly allocated either to observation (22 cases, controls) or to receive 341 mg of intramuscular 17P (23 cases, 17P group), twice a week, until 36 weeks. Just before randomization, 7 and 21 days later, a cervical swab for interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor α (TNF-α), and nitrates/nitrites (NOx) assays was collected. Moreover, an ultrasound measure of cervical length (CL) was performed at the same time. At randomization, both groups of women showed similar levels of cervical ILs and NOx. In the 17P group, cervical IL-1β levels were significantly decreased at day 21 (p = 0.036); in controls, they remained stable throughout the observation period. There was no significant change in IL-6, IL-8, TNF-α, and NOx in either group. Women in the control group had a progressive CL shortening until day 21 (median shortening of 4 mm), and this shortening was significantly less in the 17P group (median shortening of 2 mm; p = 0.017). In patients at risk of preterm labor, high-dose 17P simultaneously inhibits both cervical proinflammatory IL-1β secretion and the progressive shortening of the cervix.

REFERENCES

• 1 Johnson J W, Austin K L, Jones G S, Davis G H, King T M. Efficacy of 17-α-hydroxyprogesterone caproate in the prevention of premature labor.  N Engl J Med. 1975;  293 675-680
  PubMedGoogle Scholar
• 2 Erny R, Pigne A, Prouvost C et al.. The effects of oral administration of progesterone for premature labor.  Am J Obstet Gynecol. 1986;  154 525-529
  PubMedGoogle Scholar
• 3 Meis P J, Klebanoff M, Thom E, Dombrowski M P, Sibai B, Moawad A H. Prevention of recurrent preterm delivery by alpha-hydroxyprogesterone caproate.  N Engl J Med. 2003;  348 2379-2385
  CrossrefPubMedGoogle Scholar
• 4 Sfakianaki A K, Norwitz E R. Mechanisms of progesterone action in inhibiting prematurity.  J Mat Fet Neonat Med. 2006;  19 763-72
  PubMedGoogle Scholar
• 5 Liggins G. Cervical ripening as an inflammatory reaction. In: Ellwood D, Anderson A The Cervix in Pregnancy and Labour. Clinical and Biochemical Investigations. Edinburgh; Churchill Livingstone 1981
  Google Scholar
• 6 Facchinetti F, Venturini P, Blasi I, Giannella L. Changes in the cervical competence in preterm labour.  BJOG. 2005;  112(Suppl 1) 23-27
  PubMedGoogle Scholar
• 7 Sennström M B, Ekman G, Westergren-Thorsson G et al.. Human cervical ripening, an inflammatory process mediated by cytokines.  Mol Hum Reprod. 2000;  6 375-381
  CrossrefPubMedGoogle Scholar
• 8 Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17α-hydroxy-progesterone caproate.  Am J Obstet Gynecol. 2007;  196 453e1-453e4
  CrossrefPubMedGoogle Scholar
• 9 Berghella V, Ness A, Bega G, Berghella M. Cervical sonography in women with symptoms of preterm labour.  Obstet Gynecol Clin North Am. 2005;  32 383-396
  CrossrefPubMedGoogle Scholar
• 10 Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palcovics T, Szereday L. Progesterone as an immunomodulatory molecule.  Int Immunopharmacol. 2001;  1 1037-1048
  CrossrefPubMedGoogle Scholar
• 11 Cakmak H, Schatz F, Huang S-TJ et al.. Progestin suppresses thrombin- and interleukin-1β- induced interleukin-11 production in term decidual cells: implications for preterm delivery.  J Clin Endocrinol Metab. 2005;  90 5279-5286
  CrossrefPubMedGoogle Scholar
• 12 Elovitz M A, Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model.  Am J Obstet Gynecol. 2006;  195 1004-1010
  CrossrefPubMedGoogle Scholar
• 13 Sadowsky D W, Adams K M, Gravett M G, Witkin S S, Novy M J. Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a non human primate model.  Am J Obstet Gynecol. 2006;  195 1578-1589
  CrossrefPubMedGoogle Scholar
• 14 Tanaka Y, Narahara H, Takai N, Yoshimatsu J, Anai T, Miyakawa I. Interleukin-1 beta and interleukin-8 in cervicovaginal fluid during pregnancy.  Am J Obstet Gynecol. 1998;  179 644-649
  CrossrefPubMedGoogle Scholar
• 15 Edwards R K, Ferguson R J, Duff P. The interleukin-1β + 3953 single nucleotide polymorphism: cervical protein concentration and preterm delivery risk.  Am J Reprod Immunol. 2006;  55 259-264
  CrossrefPubMedGoogle Scholar
• 16 Romero R, Brody D T, Oyarzun E et al.. Infection and labor. III. Interleukin-1: a signal for the onset of parturition.  Am J Obstet Gynecol. 1989;  160 1117-1123
  PubMedGoogle Scholar
• 17 Fonseca E B, Celik E, Parra M, Singh M, Kypros H, Nicolaides K H. Progesterone and the risk of preterm birth among women with a short cervix.  N Engl J Med. 2007;  357 462-469
  CrossrefPubMedGoogle Scholar
• 18 Dodd J M, Flenady V, Cincotta R, Crowther C A. Prenatal administration of progesterone for preventing preterm birth.  , (Review) Cochrane Database Syst Rev. 2006;  25 CD004947
  PubMedGoogle Scholar

Prof. Fabio Facchinetti

U.O. Ostetricia e Ginecologia, Dip. Materno Infantile

Via del Pozzo 71, 41100 Modena, Italy

Email: Facchi@unimore.it